Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Osteosarcoma | Research

Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma

Authors: Xiao-chun Wang, Ling Zhang, Jiong-bin Lin, Xiao-yao Huang, Jing-hong Liang, Jian-ping Zhong, Ji-dong Peng, Jun-yuan Zhong

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Objective

The aim of this study was to investigate the clinical, imaging and pathological features of extraskeletal osteosarcoma (EOS) and to improve the understanding of this disease and other similar lesions.

Methods

The data for 11 patients with pathologically confirmed extraosseous osteosarcoma, including tumour site and size and imaging and clinical manifestations, were analysed retrospectively.

Results

Six patients were male (60%), and 5 were female (40%); patient age ranged from 23 to 76 years (average age 47.1 years). Among the 11 patients, 7 had clear calcifications or ossification with different morphologies, and 2 patients showed a massive mature bone tumour. MRI showed a mixed-signal mass with slightly longer T1 and T2 signals in the tumour parenchyma. Enhanced CT and MRI scans showed enhancement in the parenchyma. Ten patients had different degrees of necrosis and cystic degeneration in the mass, 2 of whom were complicated with haemorrhage, and MRI showed “fluid‒fluid level” signs. Of the 11 patients, five patients survived after surgery, and no obvious recurrence or metastasis was found on imaging examination. One patient died of lung metastasis after surgery, and 2 patients with open biopsy died of disease progression. One patient died of respiratory failure 2 months after operation. 2 patients had positive surgical margins, and 1 had lung metastasis 6 months after operation and died 19 months after operation. Another patient had recurrence 2 months after surgery.

Conclusion

The diagnosis of EOS requires a combination of clinical, imaging and histological examinations. Cystic degeneration and necrosis; mineralization is common, especially thick and lumpy mineralization. Extended resection is still the first choice for localized lesions. For patients with positive surgical margins or metastases, adjuvant chemoradiotherapy is needed.
Literature
1.
go back to reference Wang H, et al. Extraskeletal osteosarcoma: a large series treated at a single institution. Rare Tumors. 2018;10:203636131774965.CrossRef Wang H, et al. Extraskeletal osteosarcoma: a large series treated at a single institution. Rare Tumors. 2018;10:203636131774965.CrossRef
2.
go back to reference Roller LA, et al. Clinical, radiological, and pathological features of extraskeletal osteosarcoma. Skeletal Radiol. 2018;47(9):1213–20.CrossRefPubMed Roller LA, et al. Clinical, radiological, and pathological features of extraskeletal osteosarcoma. Skeletal Radiol. 2018;47(9):1213–20.CrossRefPubMed
3.
go back to reference Longhi A, et al. Extraskeletal osteosarcoma: a European Musculoskeletal Oncology Society study on 266 patients. Eur J Cancer. 2017;74:9–16.CrossRefPubMed Longhi A, et al. Extraskeletal osteosarcoma: a European Musculoskeletal Oncology Society study on 266 patients. Eur J Cancer. 2017;74:9–16.CrossRefPubMed
4.
go back to reference Bane BL, et al. Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer. 1990;65(12):2762–70.CrossRefPubMed Bane BL, et al. Extraskeletal osteosarcoma. A clinicopathologic review of 26 cases. Cancer. 1990;65(12):2762–70.CrossRefPubMed
5.
go back to reference Veselis CA, et al. Bone tumors occurring in the soft tissues: a review of the clinical, imaging, and histopathologic findings. Curr Probl Diagn Radiol. 2021;50(3):419–29.CrossRefPubMed Veselis CA, et al. Bone tumors occurring in the soft tissues: a review of the clinical, imaging, and histopathologic findings. Curr Probl Diagn Radiol. 2021;50(3):419–29.CrossRefPubMed
7.
go back to reference Mc AG, et al. Extraskeletal osteosarcoma: spectrum of imaging findings. AJR Am J Roentgenol. 2012;198(1):W31-37.CrossRef Mc AG, et al. Extraskeletal osteosarcoma: spectrum of imaging findings. AJR Am J Roentgenol. 2012;198(1):W31-37.CrossRef
9.
go back to reference Lee JS, et al. A review of 40 patients with extraskeletal osteosarcoma. Cancer. 1995;76(11):2253–9.CrossRefPubMed Lee JS, et al. A review of 40 patients with extraskeletal osteosarcoma. Cancer. 1995;76(11):2253–9.CrossRefPubMed
10.
go back to reference Bartlett H, et al. Radiation-associated primary osteosarcoma of the breast. Pathobiology. 2020;87(5):322–6.CrossRefPubMed Bartlett H, et al. Radiation-associated primary osteosarcoma of the breast. Pathobiology. 2020;87(5):322–6.CrossRefPubMed
11.
go back to reference WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. WHO classification of tumours series. 3rd ed. Lyon: International Agency for Research on Cancer; 2020. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. WHO classification of tumours series. 3rd ed. Lyon: International Agency for Research on Cancer; 2020.
13.
go back to reference Heng M, et al. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Eur J Cancer. 2020;125:130–41.CrossRefPubMed Heng M, et al. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma. Eur J Cancer. 2020;125:130–41.CrossRefPubMed
15.
go back to reference Zhang J, et al. Primary exophytic extraskeletal osteosarcoma of the liver: a case report and literature review. Risk Manag Healthc Policy. 2021;14:1009–14.CrossRefPubMedPubMedCentral Zhang J, et al. Primary exophytic extraskeletal osteosarcoma of the liver: a case report and literature review. Risk Manag Healthc Policy. 2021;14:1009–14.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Dubec JJ, et al. Soft tissue osteosarcoma with telangiectatic features: MR imaging findings in two cases. Skeletal Radiol. 1997;26(12):732–6.CrossRefPubMed Dubec JJ, et al. Soft tissue osteosarcoma with telangiectatic features: MR imaging findings in two cases. Skeletal Radiol. 1997;26(12):732–6.CrossRefPubMed
19.
go back to reference Zishan US, et al. The differentiation between aneurysmal bone cyst and telangiectatic osteosarcoma: a clinical, radiographic and MRI study. Skeletal Radiol. 2020;49(9):1375–86.CrossRefPubMed Zishan US, et al. The differentiation between aneurysmal bone cyst and telangiectatic osteosarcoma: a clinical, radiographic and MRI study. Skeletal Radiol. 2020;49(9):1375–86.CrossRefPubMed
21.
go back to reference Amendola MA, et al. Myositis ossificans circumscripta: computed tomographic diagnosis. Radiology. 1983;149(3):775–9.CrossRefPubMed Amendola MA, et al. Myositis ossificans circumscripta: computed tomographic diagnosis. Radiology. 1983;149(3):775–9.CrossRefPubMed
22.
23.
go back to reference Mormile I, et al. Calcinosis cutis and calciphylaxis in autoimmune connective tissue diseases. Vaccines (Basel). 2023;11(5):898.CrossRefPubMed Mormile I, et al. Calcinosis cutis and calciphylaxis in autoimmune connective tissue diseases. Vaccines (Basel). 2023;11(5):898.CrossRefPubMed
24.
go back to reference Jakowski JD, Wakely PJ. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Cancer. 2007;111(5):298–305.CrossRefPubMed Jakowski JD, Wakely PJ. Cytopathology of extraskeletal myxoid chondrosarcoma: report of 8 cases. Cancer. 2007;111(5):298–305.CrossRefPubMed
25.
go back to reference Santos F, Martins C, Lemos MM. Fine-needle aspiration features of extraskeletal myxoid chondrosarcoma: a study of cytological and molecular features. Diagn Cytopathol. 2018;46(11):950–7.CrossRefPubMed Santos F, Martins C, Lemos MM. Fine-needle aspiration features of extraskeletal myxoid chondrosarcoma: a study of cytological and molecular features. Diagn Cytopathol. 2018;46(11):950–7.CrossRefPubMed
26.
go back to reference Murphey MD, et al. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics. 2003;23(5):1245–78.CrossRefPubMed Murphey MD, et al. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics. 2003;23(5):1245–78.CrossRefPubMed
27.
go back to reference Hayashida K, et al. G-CSF production by undifferentiated pleomorphic sarcoma with leukemoid reaction occurred in the lower leg: a case report. JBJS Case Connect. 2020;10(2):e0624.CrossRefPubMed Hayashida K, et al. G-CSF production by undifferentiated pleomorphic sarcoma with leukemoid reaction occurred in the lower leg: a case report. JBJS Case Connect. 2020;10(2):e0624.CrossRefPubMed
28.
go back to reference Bixby SD, et al. Synovial sarcoma in children: imaging features and common benign mimics. AJR Am J Roentgenol. 2010;195(4):1026–32.CrossRefPubMed Bixby SD, et al. Synovial sarcoma in children: imaging features and common benign mimics. AJR Am J Roentgenol. 2010;195(4):1026–32.CrossRefPubMed
29.
go back to reference Bakri A, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199(2):W208-215.CrossRefPubMed Bakri A, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199(2):W208-215.CrossRefPubMed
30.
go back to reference O’Sullivan PJ, Harris AC, Munk PL. Radiological features of synovial cell sarcoma. Br J Radiol. 2008;81(964):346–56.CrossRefPubMed O’Sullivan PJ, Harris AC, Munk PL. Radiological features of synovial cell sarcoma. Br J Radiol. 2008;81(964):346–56.CrossRefPubMed
31.
go back to reference Goldstein-Jackson SY, et al. Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol. 2005;131(8):520–6.CrossRefPubMed Goldstein-Jackson SY, et al. Extraskeletal osteosarcoma has a favourable prognosis when treated like conventional osteosarcoma. J Cancer Res Clin Oncol. 2005;131(8):520–6.CrossRefPubMed
32.
go back to reference Jour G, et al. The molecular landscape of extraskeletal osteosarcoma: a clinicopathological and molecular biomarker study. J Pathol Clin Res. 2016;2(1):9–20.CrossRefPubMed Jour G, et al. The molecular landscape of extraskeletal osteosarcoma: a clinicopathological and molecular biomarker study. J Pathol Clin Res. 2016;2(1):9–20.CrossRefPubMed
34.
go back to reference Tsukamoto S, et al. The effect of adjuvant chemotherapy on localized extraskeletal osteosarcoma: a systematic review. Cancers (Basel). 2022;14(10):2559.CrossRefPubMed Tsukamoto S, et al. The effect of adjuvant chemotherapy on localized extraskeletal osteosarcoma: a systematic review. Cancers (Basel). 2022;14(10):2559.CrossRefPubMed
35.
go back to reference Chen J, et al. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(7):1205–10.CrossRefPubMed Chen J, et al. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(7):1205–10.CrossRefPubMed
36.
go back to reference Marais LC, et al. Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcoma. J Bone Oncol. 2015;4(3):80–4.CrossRefPubMedPubMedCentral Marais LC, et al. Pre-treatment serum lactate dehydrogenase and alkaline phosphatase as predictors of metastases in extremity osteosarcoma. J Bone Oncol. 2015;4(3):80–4.CrossRefPubMedPubMedCentral
37.
go back to reference Ren HY, et al. Prognostic significance of serum alkaline phosphatase level in osteosarcoma: a meta-analysis of published data. Biomed Res Int. 2015;2015:160835.CrossRefPubMedPubMedCentral Ren HY, et al. Prognostic significance of serum alkaline phosphatase level in osteosarcoma: a meta-analysis of published data. Biomed Res Int. 2015;2015:160835.CrossRefPubMedPubMedCentral
Metadata
Title
Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma
Authors
Xiao-chun Wang
Ling Zhang
Jiong-bin Lin
Xiao-yao Huang
Jing-hong Liang
Jian-ping Zhong
Ji-dong Peng
Jun-yuan Zhong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11731-3

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine